|
FAM21A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.572200E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.558500E-04 |
| Normal-vs-Stage2 |
1.016090E-02 |
| Normal-vs-Stage3 |
5.150500E-02 |
| Normal-vs-Stage4 |
8.582500E-03 |
| Stage1-vs-Stage2 |
9.894600E-01 |
| Stage1-vs-Stage3 |
7.199600E-01 |
| Stage1-vs-Stage4 |
5.493000E-01 |
| Stage2-vs-Stage3 |
7.705200E-01 |
| Stage2-vs-Stage4 |
5.250400E-01 |
| Stage3-vs-Stage4 |
4.605000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.024100E-04 |
| Normal-vs-AfricanAmerican |
5.257500E-02 |
| Normal-vs-Asian |
9.856200E-01 |
| Caucasian-vs-AfricanAmerican |
7.017600E-02 |
| Caucasian-vs-Asian |
3.469400E-01 |
| AfricanAmerican-vs-Asian |
4.262600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.373200E-04 |
| Normal-vs-Female |
9.691900E-02 |
| Male-vs-Female |
3.038100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.720800E-03 |
| Normal-vs-Extreme_Weight |
3.66550000000521E-05 |
| Normal-vs-Obese |
2.081900E-03 |
| Normal-vs-Extreme_Obese |
1.690820E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.427400E-01 |
| Normal_Weight-vs-Obese |
6.782800E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.152200E-01 |
| Extreme_Weight-vs-Obese |
1.335040E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.757580E-01 |
| Obese-vs-Extreme_Obese |
5.289200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.744400E-01 |
| Normal-vs-Age(41-60Yrs) |
9.217700E-03 |
| Normal-vs-Age(61-80Yrs) |
1.438550E-04 |
| Normal-vs-Age(81-100Yrs) |
2.358400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.912200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.365800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.083500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.922500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.890400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.608000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.21870000000268E-05 |
| Normal-VS-Type2 PRCC |
7.066100E-02 |
| Normal-VS-KIRP CIMP |
2.685500E-02 |
| Normal-VS-Unclassified PRCC |
1.536570E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.334100E-02 |
| Type1 PRCC-VS-KIRP CIMP |
8.339800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.822300E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.969600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.660800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.780200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.064800E-03 |
| Normal-vs-N1 |
1.511360E-01 |
| Normal-vs-N2 |
3.090200E-02 |
| N0-vs-N1 |
3.336200E-01 |
| N0-vs-N2 |
4.728600E-01 |
| N1-vs-N2 |
3.029000E-01 |
|
|
